Tibet Pharmaceuticals: The deduction of non-net profit in the first three quarters exceeded 400 million yuan, a year-on-year increase of 47%

According to Securities Times e Company, on the evening of October 27, Tibet Pharmaceutical (600211) released its third quarterly report. During the period from January to September this year, the company achieved operating income of 1.562 billion yuan, an increase of 57.83% year-on-year; net profit of 418 million yuan, an increase of year-on-year 28.98%; deducted non-net profit of 417 million yuan, a year-on-year increase of 47.1%. Among them, in the single quarter of the third quarter, Tibet Pharmaceuticals achieved operating income of 524 million yuan, a year-on-year increase of 45.13%; net profit was 120 million yuan, a year-on-year increase of 15.02%. Tibet Pharmaceutical said that the increase in revenue was mainly due to the increase in sales of its Xinhuo Su.